Journal
HAEMATOLOGICA
Volume 103, Issue 8, Pages 1256-1268Publisher
FERRATA STORTI FOUNDATION
DOI: 10.3324/haematol.2017.184192
Keywords
-
Categories
Ask authors/readers for more resources
Evading immune eradication is a prerequisite for neoplastic progression and one of the hallmarks of cancer. Here, we review the different immune escape strategies of lymphoma and classify them into two main mechanisms. First, lymphoma cells may hide to become invisible to the immune system. This can be achieved by losing or down-regulating MHC and/or molecules involved in antigen presentation (including antigen processing machinery and adhesion molecules), thereby preventing their recognition by the immune system. Second, lymphoma cells may defend themselves to become resistant to immune eradication. This can be achieved in several ways: by becoming resistant to apoptosis, by expressing inhibitory ligands that deactivate immune cells and/or by inducing an immunosuppressive (humoral and cellular) microenvironment. These immune escape mechanisms may have therapeutic implications. Their identification may be used to guide personalized immunotherapy for lymphoma.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available